PerkinElmer At a Glance
We are a global company committed to innovating for a healthier world. We create the instruments, tests, software and services used by scientists, researchers and clinicians to address the most critical challenges across science and healthcare.
Driving positive outcomes through precision diagnostics
With $2.9 billion in revenue for 2021, PerkinElmer Diagnostics is a major player in the in vitro diagnostics market. Operating on a global scale, we offer innovative and complete solutions, including instruments, reagents, automation, services and software, designed to serve multiple end users and needs.